Becton Dickinson/Luther Medical
This article was originally published in The Gray Sheet
Executive Summary
Becton Dickinson increases to $4.70 from $4.62-per-share its October bid for each of Luther Medical Products' roughly 3.2 mil. outstanding common stock shares, Luther reports Dec. 8. Terms of the revised deal also call for Luther to grant BD a six-month option for an 18-month license to a Luther needle stick protection patent. The patent relates to technology, for which FDA market clearance was simultaneously announced, that "has the capability of providing a needle stick protection feature to approximately half of the Luther Medical product range," Luther says. In the event that BD fails to consummate the merger, BD would pay Luther $325,000 cash in consideration of the patent option, followed by an additional $200,000 if BD decides to exercise that option
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.